Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences.
about
Drug Resistance Is Not Directly Affected by Mating Type Locus Zygosity in Candida albicansProbiotics for vulvovaginal candidiasis in non-pregnant womenCiclopirox olamine treatment affects the expression pattern of Candida albicans genes encoding virulence factors, iron metabolism proteins, and drug resistance factorsEmerging Threats in Antifungal-Resistant Fungal PathogensThe ABCs of Candida albicans Multidrug Transporter Cdr1Mechanisms of Candida biofilm drug resistanceCandida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agentsTipping the balance both ways: drug resistance and virulence in Candida glabrataAntimicrobial peptides for therapeutic applications: a reviewCryptococcus neoformans overcomes stress of azole drugs by formation of disomy in specific multiple chromosomesGain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulenceProteomic analysis of Rta2p-dependent raft-association of detergent-resistant membranes in Candida albicansFitness trade-offs restrict the evolution of resistance to amphotericin BNew Mechanisms of Flucytosine Resistance in C. glabrata Unveiled by a Chemogenomics Analysis in S. cerevisiaeAntifungal Therapy: New Advances in the Understanding and Treatment of MycosisSensitivity of clinical isolates of Candida to essential oils from Burseraceae familyCandida rugosa, an emerging fungal pathogen with resistance to azoles: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic locationAdhesion of Candida albicans to endothelial cells under physiological conditions of flowIdentification of essential genes in the human fungal pathogen Aspergillus fumigatus by transposon mutagenesis.Chemosensitization of fluconazole resistance in Saccharomyces cerevisiae and pathogenic fungi by a D-octapeptide derivative.Candidaemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible links.Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing.Overcoming antifungal resistance.Molecular epidemiology and azole resistance mechanism study of Candida guilliermondii from a Chinese surveillance system.Rapid quantification of drug resistance gene expression in Candida albicans by reverse transcriptase LightCycler PCR and fluorescent probe hybridization.Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003.Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole.Contribution of CgPDR1-regulated genes in enhanced virulence of azole-resistant Candida glabrataInactivation of sterol Delta5,6-desaturase attenuates virulence in Candida albicansA screening assay based on host-pathogen interaction models identifies a set of novel antifungal benzimidazole derivatives.Piperazinyl quinolines as chemosensitizers to increase fluconazole susceptibility of Candida albicans clinical isolates.Oral Candida isolates colonizing or infecting human immunodeficiency virus-infected and healthy persons in Mexico.In vivo systematic analysis of Candida albicans Zn2-Cys6 transcription factors mutants for mice organ colonization.Possible inhibitory molecular mechanism of farnesol on the development of fluconazole resistance in Candida albicans biofilm.Application of real-time quantitative PCR to molecular analysis of Candida albicans strains exhibiting reduced susceptibility to azoles.Polymer multilayers loaded with antifungal β-peptides kill planktonic Candida albicans and reduce formation of fungal biofilms on the surfaces of flexible catheter tubes.Azole resistance by loss of function of the sterol Δ⁵,⁶-desaturase gene (ERG3) in Candida albicans does not necessarily decrease virulenceResistance to antifungals that target CYP51.Urban legends series: oral candidosis.
P2860
Q22337052-E5BAB65D-8A32-4A6A-A749-83C867B32047Q24198021-0BE55D54-A2AC-4459-A9B0-0D9F0F7D63D9Q24670154-D893752A-0AB7-44C4-BDBD-BE4A04E6E703Q26750816-D3979CD7-D454-45E9-B447-9CAD95121C8CQ26786747-6BF624EE-19C3-4FC7-81DC-57383E5DEDDEQ26827521-967C7DB1-1502-41B9-816C-BE08B4F97979Q26863344-40B06327-4766-4B96-BA3D-A1D2171910FFQ26996199-41883929-A59A-4953-BEE7-6D938E17295CQ27004635-57DEFFD6-B766-4682-8E43-A67B173F17E9Q27315103-03285BB2-C032-471A-A3EC-A19363C83408Q27318203-F52702CD-3132-4FC0-97D5-42CE0284B186Q28483932-84BBA45D-6CED-45C8-B9EB-D19E68CEB5B8Q28534687-57B59B91-34BF-4817-B32E-8337E21AC80CQ28547198-D12E028B-6885-45CC-AA93-D7C521846E46Q28818603-E48282DB-10B1-480A-94FA-D4F3B07D4755Q28830247-F234AA1A-F4D1-42EC-A1DB-9E5F0706EA47Q30445379-E9B56995-917B-4E7E-9992-3B31E6AB294BQ30452976-47EA0BFC-AC50-44CF-8F16-0B49C6FC80C6Q30489995-7C9D5003-634D-446D-BE75-37CA3E50EDF0Q30913384-7F130A2D-422E-41A4-9A4A-4A27A2708ACAQ33200348-8FC034A0-6D3C-4070-9896-56676E386050Q33241991-8E29BFB8-E0BA-4D28-8C8B-4F000EF8ABF4Q33493582-6B01A08B-A031-472F-BD0A-57984579E852Q33651853-BC276EB4-3994-4ACB-B018-AAC77F48527FQ33680814-3D2981DD-4DAE-440C-939F-013DD976D17BQ33715355-3D39FAA2-AF49-4E53-8E9B-29B5B3DEAC34Q33753405-96148172-4CDF-432E-9F5B-3FF6C54A7FF3Q33806807-A5E693CE-3499-4DC6-93AB-880EDDD27450Q33847058-D260C71D-2E5B-4515-8179-26A9DBE67895Q33935383-4744AD6C-6439-4111-A68C-C82A41047FABQ33957538-8AB5A047-C574-437C-9FE0-A0C73AC8841EQ33976044-1DFE6454-80B5-441B-A6C5-C948E486900EQ34041589-15F955AF-B244-476E-A62B-E78DC62D044CQ34071444-B7C50836-F415-4FF9-B0AD-FF4502BC3006Q34079974-15C6B25B-C018-48DF-B5B3-0F56D5F63A16Q34141180-38D05E72-932F-4F68-8A45-850E65F246B2Q34145535-9607F223-ECC7-4010-90F0-ABDD29D4D5E9Q34247781-4C629C52-49AC-4267-BB04-807209FC2406Q34276700-7CF50761-AF85-4AE3-9EE8-8D2D3C049796Q34301094-330FCB44-419F-4049-9704-4AE5F8E82BB9
P2860
Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Resistance of Candida species ...... sms and clinical consequences.
@ast
Resistance of Candida species ...... sms and clinical consequences.
@en
Resistance of Candida species ...... sms and clinical consequences.
@nl
type
label
Resistance of Candida species ...... sms and clinical consequences.
@ast
Resistance of Candida species ...... sms and clinical consequences.
@en
Resistance of Candida species ...... sms and clinical consequences.
@nl
prefLabel
Resistance of Candida species ...... sms and clinical consequences.
@ast
Resistance of Candida species ...... sms and clinical consequences.
@en
Resistance of Candida species ...... sms and clinical consequences.
@nl
P1476
Resistance of Candida species ...... sms and clinical consequences.
@en
P2093
Frank C Odds
P356
10.1016/S1473-3099(02)00181-0
P577
2002-02-01T00:00:00Z